Publications by authors named "K Fakes"
Aims: To examine survivors' experiences of discharge information including risk communication after hospitalisation for a stroke and the characteristics associated with receiving information in accordance with their preferences.
Background: With advances in acute stroke care and an ageing population, the number of survivors of stroke is increasing. It is important that healthcare providers ensure patients have adequate information after a stroke-related hospitalisation.
Background: Cardiovascular disease (CVD) is a leading cause of morbidity and mortality and residing in a rural and remote region is associated with an increased risk. The impact of rurality on CVD outcomes needs to be fully elucidated.
Objectives: The purpose of this study was to assess the difference in mortality, readmission within 30 days, total readmissions, survival, and total emergency department (ED) presentations following an index CVD admission among patients from rural or remote areas as compared to metropolitan areas.
Study Objective: Early detection of systemic envenoming is critical for early antivenom therapy to minimize morbidity and mortality from snakebite. We assessed the diagnostic utility of 3 serum biomarkers in the early detection of systemic envenoming in viper bites in rural Sri Lanka.
Methods: All confirmed snakebite patients admitted to Teaching Hospital Anuradhapura from July 2020 to June 2021 were included.
Purpose/objective: To examine, among survivors of stroke: (a) the prevalence of and most frequently reported unmet needs; and (b) the sociodemographic and clinical factors associated with higher counts of unmet needs.
Research Method/design: A cross-sectional study was undertaken with survivors of stroke recently discharged from eight hospitals in Australia, with institutional board approval. Survivors were mailed one survey for completion after their discharge from hospital.
Article Synopsis
- Antivenom is the standard treatment for snake bites globally, yet its effectiveness has had limited clinical trials to back it up, prompting a study on its impact on myotoxicity in red-bellied black snake bites.* -
- This study was a multicenter randomized placebo-controlled trial involving patients from the Australian Snakebite Project, comparing early administration of tiger snake antivenom to a placebo within six hours post-bite.* -
- Results indicated that none of the patients treated with antivenom showed peak creatine kinase activity over 1,000 U/L, while 29% of the placebo group did; however, the statistical difference was not significant (p=0.2), suggesting antivenom may help